BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis

Chronic pain, such as persistent inflammatory pain, remains a public health problem that has no effective treatment at present. Bromodomain-containing protein 4 (BRD4) inhibition, induced by JQ1 injection or BRD4 knockdown, has been used to attenuate inflammatory pain; However, it remains elusive whether BRD4 aggravates inflammatory pain by regulating inflammasome. Western blot and immunofluorescence staining showed that BRD4 expression increased after administration of complete Freund’s adjuvant (CFA) and reached its peak on day 3. Immunofluorescence staining showed that BRD4 was mainly colocalized with NeuN-positive neurons in the spinal cord, which was accompanied by upregulation of inflammasome component proteins, such as NLRP3, gasdermin D, and caspase-1. JQ1 was intrathecally injected into mice 1 h before CFA administration, and the mechanical and thermal hyperalgesia levels were measured on days 1, 3, and 7 after CFA administration. CFA-induced inflammatory pain, paw inflammation, and swelling were attenuated by pre-treatment with JQ1. To our knowledge, this study was the first to prove that NLRP3 inflammasome-induced neuronal pyroptosis participates in inflammatory pain. BRD4 inhibition decreased the expression of pyroptosis-related proteins by inhibiting the activation of NF-κB signaling pathway, both in vivo and in vitro. Taken together, BRD4 inhibition exerted analgesic and anti-inflammatory effects against inflammatory pain by inhibiting NF-κB and inflammasome activation, which protected neural cells from pyroptosis.

[1]  Lingyun Sun,et al.  Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy , 2021, Redox biology.

[2]  Z. Xiang,et al.  S100A4 in Spinal Substantia Gelatinosa from Dorsal Root Ganglia Modulates Neuropathic Pain in a Rodent Spinal Nerve Injury Model , 2021, Journal of pain research.

[3]  Xuyu Zu,et al.  JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS , 2021, Frontiers in Immunology.

[4]  Si-Si Liang,et al.  Downregulation of HOTAIR reduces neuronal pyroptosis by targeting miR-455-3p/NLRP1 axis in propofol-treated neurons in vitro , 2021, Neurochemical Research.

[5]  N. Galeotti,et al.  Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain. , 2021, Pharmacological research.

[6]  Wusheng Zhu,et al.  Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury , 2020, Journal of neuroinflammation.

[7]  Yadong Chen,et al.  Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis , 2020, International journal of biological sciences.

[8]  P. Stemkowski,et al.  Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk. , 2020, Cell reports.

[9]  Lei Wang,et al.  Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis , 2020, Cell Death & Disease.

[10]  J. Lieberman,et al.  FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation , 2020, Nature Immunology.

[11]  Longyun Li,et al.  Muscone relieves inflammatory pain by inhibiting microglial activation-mediated inflammatory response via abrogation of the NOX4/JAK2-STAT3 pathway and NLRP3 inflammasome. , 2020, International immunopharmacology.

[12]  W. Shuying,et al.  Inhibitory effects of JQ1 on listeria monocytogenes-induced acute liver injury by blocking BRD4/RIPK1 axis. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  X. Navarro,et al.  BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury , 2019, Journal of Neuroinflammation.

[14]  Sheng-feng Lu,et al.  Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling , 2019, Front. Pharmacol..

[15]  T. Hales,et al.  Perioperative opioid analgesia—when is enough too much? A review of opioid-induced tolerance and hyperalgesia , 2019, The Lancet.

[16]  N. Ayad,et al.  Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury , 2018, Experimental Neurology.

[17]  Andrea Reboldi,et al.  Faculty Opinions recommendation of Inflammasomes: mechanism of assembly, regulation and signalling. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[18]  T. Hökfelt,et al.  Ca2+-binding protein NECAB2 facilitates inflammatory pain hypersensitivity , 2018, The Journal of clinical investigation.

[19]  Y. Yanagawa,et al.  NMDA Receptor Activation Underlies the Loss of Spinal Dorsal Horn Neurons and the Transition to Persistent Pain after Peripheral Nerve Injury , 2018, Cell reports.

[20]  Man Li,et al.  Electroacupuncture inhibits NLRP3 inflammasome activation through CB2 receptors in inflammatory pain , 2018, Brain, Behavior, and Immunity.

[21]  Shue Liu,et al.  Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats , 2018, Neuroreport.

[22]  Y. Chau,et al.  Bromodomain-containing Protein 4 Activates Voltage-gated Sodium Channel 1.7 Transcription in Dorsal Root Ganglia Neurons to Mediate Thermal Hyperalgesia in Rats , 2017, Anesthesiology.

[23]  Sakae Tanaka,et al.  Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB , 2017, Arthritis Research & Therapy.

[24]  Mingcheng Huang,et al.  The suppression of bromodomain and extra‐terminal domain inhibits vascular inflammation by blocking NF‐κB and MAPK activation , 2017, British journal of pharmacology.

[25]  J. Lieberman,et al.  A Mechanistic Understanding of Pyroptosis: The Fiery Death Triggered by Invasive Infection. , 2017, Advances in immunology.

[26]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[27]  G. Sartor,et al.  The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease , 2016, Current Alzheimer research.

[28]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[29]  W. Gan,et al.  Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury , 2016, Nature Communications.

[30]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[31]  Lin-Feng Chen,et al.  BET Inhibition Attenuates Helicobacter pylori–Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation , 2016, The Journal of Immunology.

[32]  Jin Choul Chai,et al.  Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1 , 2015, Scientific Reports.

[33]  B. Ryffel,et al.  Peripheral NLCR4 inflammasome participates in the genesis of acute inflammatory pain , 2015, Pain.

[34]  Jin Choul Chai,et al.  RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells , 2015, Journal of Neuroinflammation.

[35]  Zhen-Zhong Xu,et al.  Emerging targets in neuroinflammation-driven chronic pain , 2014, Nature Reviews Drug Discovery.

[36]  Blair H. Smith,et al.  Chronic pain epidemiology and its clinical relevance. , 2013, British journal of anaesthesia.

[37]  Ralf Baron,et al.  Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms , 2012, Neuron.

[38]  Ling Zhang,et al.  Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats , 2011, Molecular pain.

[39]  Charles N Serhan,et al.  Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions , 2010, Nature Medicine.

[40]  M. Bushnell,et al.  How neuroimaging studies have challenged us to rethink: is chronic pain a disease? , 2009, The journal of pain : official journal of the American Pain Society.